126 related articles for article (PubMed ID: 1647394)
1. Inhibition of virus-induced cell fusion by apolipoprotein A-I and its amphipathic peptide analogs.
Srinivas RV; Venkatachalapathi YV; Rui Z; Owens RJ; Gupta KB; Srinivas SK; Anantharamaiah GM; Segrest JP; Compans RW
J Cell Biochem; 1991 Feb; 45(2):224-37. PubMed ID: 1647394
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs.
Srinivas RV; Birkedal B; Owens RJ; Anantharamaiah GM; Segrest JP; Compans RW
Virology; 1990 May; 176(1):48-57. PubMed ID: 2158697
[TBL] [Abstract][Full Text] [Related]
3. [The physiological function of plasma apoA-I--the anti-viral effects of apoA-I and its fragments].
Hu G; Chen B; Yan X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):98-103. PubMed ID: 7987949
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.
Owens BJ; Anantharamaiah GM; Kahlon JB; Srinivas RV; Compans RW; Segrest JP
J Clin Invest; 1990 Oct; 86(4):1142-50. PubMed ID: 2170446
[TBL] [Abstract][Full Text] [Related]
5. Interaction of model class A1, class A2, and class Y amphipathic helical peptides with membranes.
Mishra VK; Palgunachari MN
Biochemistry; 1996 Aug; 35(34):11210-20. PubMed ID: 8780526
[TBL] [Abstract][Full Text] [Related]
6. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine.
Anantharamaiah GM; Jones JL; Brouillette CG; Schmidt CF; Chung BH; Hughes TA; Bhown AS; Segrest JP
J Biol Chem; 1985 Aug; 260(18):10248-55. PubMed ID: 4019510
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
Anantharamaiah GM; Garber DW; White CR
Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
[TBL] [Abstract][Full Text] [Related]
8. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
Zhu HL; Atkinson D
Biochemistry; 2004 Oct; 43(41):13156-64. PubMed ID: 15476409
[TBL] [Abstract][Full Text] [Related]
9. Effect of amino acid distribution of amphipathic helical peptide derived from human apolipoprotein A-I on membrane curvature sensing.
Tanaka M; Takamura Y; Kawakami T; Aimoto S; Saito H; Mukai T
FEBS Lett; 2013 Mar; 587(5):510-5. PubMed ID: 23347831
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein/lipid interactions: studies with synthetic polypeptides.
Sparrow JT; Gotto AM
CRC Crit Rev Biochem; 1982; 13(1):87-107. PubMed ID: 6813024
[TBL] [Abstract][Full Text] [Related]
11. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
Johnson JE; Rao NM; Hui SW; Cornell RB
Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334
[TBL] [Abstract][Full Text] [Related]
12. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly.
Palgunachari MN; Mishra VK; Lund-Katz S; Phillips MC; Adeyeye SO; Alluri S; Anantharamaiah GM; Segrest JP
Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):328-38. PubMed ID: 8620350
[TBL] [Abstract][Full Text] [Related]
13. Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
Zhu HL; Atkinson D
Biochemistry; 2007 Feb; 46(6):1624-34. PubMed ID: 17279626
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of lipid-binding properties of the N-terminal helical segments in human apolipoprotein A-I using fragment peptides.
Tanaka M; Tanaka T; Ohta S; Kawakami T; Konno H; Akaji K; Aimoto S; Saito H
J Pept Sci; 2009 Jan; 15(1):36-42. PubMed ID: 19048603
[TBL] [Abstract][Full Text] [Related]
15. Branched synthetic constructs that mimic the physico-chemical properties of apolipoprotein AI in reconstituted high-density lipoproteins.
Demoor L; Boutillon C; Fievet C; Vanloo B; Baert J; Rosseneu M; Fruchart JC; Tartar A
Eur J Biochem; 1996 Jul; 239(1):74-84. PubMed ID: 8706721
[TBL] [Abstract][Full Text] [Related]
16. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
[TBL] [Abstract][Full Text] [Related]
17. The interfacial properties of ApoA-I and an amphipathic alpha-helix consensus peptide of exchangeable apolipoproteins at the triolein/water interface.
Wang L; Atkinson D; Small DM
J Biol Chem; 2005 Feb; 280(6):4154-65. PubMed ID: 15695525
[TBL] [Abstract][Full Text] [Related]
18. Deletion of single amino acid E235 affects the structure and lipid interaction of human apolipoprotein A-I C-terminal peptides.
Tanaka T; Tanaka M; Sugiura M; Kawakami T; Aimoto S; Saito H
Chem Pharm Bull (Tokyo); 2009 May; 57(5):499-503. PubMed ID: 19420782
[TBL] [Abstract][Full Text] [Related]
19. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.
Mishra VK; Palgunachari MN; Datta G; Phillips MC; Lund-Katz S; Adeyeye SO; Segrest JP; Anantharamaiah GM
Biochemistry; 1998 Jul; 37(28):10313-24. PubMed ID: 9665740
[TBL] [Abstract][Full Text] [Related]
20. ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose.
Carballo-Jane E; Chen Z; O'Neill E; Wang J; Burton C; Chang CH; Chen X; Eveland S; Frantz-Wattley B; Gagen K; Hubbard B; Ichetovkin M; Luell S; Meurer R; Song X; Strack A; Langella A; Cianetti S; Rech F; Capitò E; Bufali S; Veneziano M; Verdirame M; Bonelli F; Monteagudo E; Pessi A; Ingenito R; Bianchi E
Bioorg Med Chem; 2010 Dec; 18(24):8669-78. PubMed ID: 21115285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
